__timestamp | Cytokinetics, Incorporated | Zoetis Inc. |
---|---|---|
Wednesday, January 1, 2014 | 17268000 | 1643000000 |
Thursday, January 1, 2015 | 19667000 | 1532000000 |
Friday, January 1, 2016 | 27823000 | 1364000000 |
Sunday, January 1, 2017 | 36468000 | 1334000000 |
Monday, January 1, 2018 | 31282000 | 1484000000 |
Tuesday, January 1, 2019 | 39610000 | 1638000000 |
Wednesday, January 1, 2020 | 52820000 | 1726000000 |
Friday, January 1, 2021 | 96803000 | 2001000000 |
Saturday, January 1, 2022 | 177977000 | 2009000000 |
Sunday, January 1, 2023 | 173612000 | 2151000000 |
Monday, January 1, 2024 | 2318000000 |
Unleashing insights
In the competitive landscape of the pharmaceutical industry, understanding the financial dynamics of companies like Zoetis Inc. and Cytokinetics, Incorporated is crucial. Over the past decade, Zoetis has consistently outpaced Cytokinetics in Selling, General, and Administrative (SG&A) expenses, reflecting its expansive market reach and operational scale. In 2023, Zoetis reported SG&A expenses that were nearly 12 times higher than those of Cytokinetics, highlighting its significant investment in marketing and administrative functions.
From 2014 to 2023, Zoetis's SG&A expenses grew by approximately 31%, while Cytokinetics saw a staggering increase of over 900%. This dramatic rise for Cytokinetics underscores its aggressive growth strategy and increasing market presence. As these companies continue to evolve, their financial strategies will play a pivotal role in shaping their future trajectories.
Novo Nordisk A/S and Zoetis Inc.: SG&A Spending Patterns Compared
Johnson & Johnson vs Zoetis Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Zoetis Inc. vs Bio-Techne Corporation
Comparing SG&A Expenses: Zoetis Inc. vs Veracyte, Inc. Trends and Insights
Selling, General, and Administrative Costs: Zoetis Inc. vs Protagonist Therapeutics, Inc.
Breaking Down SG&A Expenses: Zoetis Inc. vs BioCryst Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Regeneron Pharmaceuticals, Inc. and Cytokinetics, Incorporated
Operational Costs Compared: SG&A Analysis of Bio-Techne Corporation and Cytokinetics, Incorporated
Who Optimizes SG&A Costs Better? Exelixis, Inc. or Cytokinetics, Incorporated
Comparing SG&A Expenses: Jazz Pharmaceuticals plc vs Cytokinetics, Incorporated Trends and Insights
Selling, General, and Administrative Costs: Cytokinetics, Incorporated vs Vericel Corporation
SG&A Efficiency Analysis: Comparing Cytokinetics, Incorporated and Agios Pharmaceuticals, Inc.